DCN Dx, a specialist in diagnostics development, manufacturing, regulatory consulting, and clinical research, today announced the launch of a new prospective biospecimen collections offering, ...
On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...
The ISPOR Glasgow panel conveyed a constructive, forward looking mood: JCA can work – and work better over time – if ...
The Financial Conduct Authority (FCA) has published updated proposals to its Value for Money (VFM) Framework consultation.
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
The UK government and trust-based pensions regulator have backed new value for money proposals for the defined contribution ...
Union argued requirement contradicted collective agreement, disproportionately affected employees on maternity leave ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
Oncoscope launches the first Real-time, AI-supported Living Systematic Literature Review designed for enterprise-wide ...
Financial Conduct Authority (FCA), and The Pensions Regulator (TPR) have launched a consultation on the value for money (VfM) ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback